Charles River Laboratories International, Inc. is a global provider of drug discovery, nonclinical development and laboratory services for pharmaceutical, biotechnology and medical device companies, as well as academic and government research institutions. The company supports customers throughout the development process, from early-stage research and target identification through preclinical testing and regulatory preparation.
Its offerings include research models and related products, discovery and development services, toxicology and safety assessment, efficacy testing, bioanalysis, and laboratory testing. Charles River also provides microbial solutions, biologics and chemistry services, and support for cell and gene therapy development and manufacturing. These services are designed to help customers evaluate potential therapies and advance them toward clinical development.
Founded in 1947, Charles River Laboratories serves customers through operations in North America, Europe, Asia and other international markets. The company is headquartered in Wilmington, Massachusetts, and has built its business through a combination of internal capabilities and acquisitions across the life sciences services industry.
AI Generated. May Contain Errors.
